First experience of 100 clinical F-18 florbetapir (Amyvid) PET/CT scans in the investigation of cognitive impairment: imaging characteristics, inter-observer agreement, confidence of read and clinical outcomes

File(s)

Khan_EANM Amyloid PET abstract.doc (40.5 KB)

Accepted version

Show more

Author(s)

Khan, SR

Patel, NH

Wallitt, KL

Soneji, ND

Fakhry-Darian, D

more

Type

Conference Paper

Date Issued

2016-10-01

Date Acceptance

2016-10-01

Citation

European Journal of Nuclear Medicine and Molecular Imaging, 2016, 43, pp.S624-S624

URI

http://hdl.handle.net/10044/1/53524

DOI

https://www.dx.doi.org/10.1007/s00259-016-3484-4

ISSN

1619-7070

Publisher

Springer Verlag

Start Page

S624

End Page

S624

Journal / Book Title

European Journal of Nuclear Medicine and Molecular Imaging

Volume

43

Copyright Statement

© 2016 Springer. The final publication is available at Springer via https://link.springer.com/journal/259/43/1/suppl/page/1

Identifier

http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000391802500359&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202

Source

Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)

Subjects

Science & Technology

Life Sciences & Biomedicine

Radiology, Nuclear Medicine & Medical Imaging

Publication Status

Published

Start Date

2016-10-15

Finish Date

2016-10-19

Coverage Spatial

Barcelona, Spain